Allison Bayer

ASO PROF

MD-PATHOLOGY

sort by:

GRANT
Microgels for localized immune control in beta cell replacement
National Institute of Health Niddk6 Aug 2026 - 31 May 2031
Active
GRANT
Restoration of immune regulation in type 1 diabetes through the synergistic action of insulin-like growth factor-1 and interleukin-2
Breakthrough T1d - Formerly Jdrf International27 Aug 2024 - 31 Oct 2026
Active
GRANT
Role of mTORC1 signaling in type 1 diabetes
National Institute of Health Niddk9 Jul 2024 - 31 Mar 2026
Expired
GRANT
Combination therapy with Ladarixin and anti-CD3 for the prevention of Type 1 diabetes in NOD mice
Dompe Pharmaceuticals13 Jun 2024 - 30 Jun 2026
Expired
GRANT
Use of dimethyl fumarate for targeting autoimmunity in type 1 diabetes
National Institute of Health Niaid25 Apr 2024 - 31 Aug 2024
Expired
GRANT
GLUT1 Inhibition in type 1 diabetes
Breakthrough T1d - Formerly Jdrf International17 Apr 2024 - 31 Jul 2026
Expired
GRANT
Conformal islet encapsulation for transplantation at vascularized sites to allow physiological insulin secretion
National Institute of Health Niddk25 Mar 2024 - 28 Feb 2029
Active
GRANT
Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation
Breakthrough T1d - Formerly Jdrf International1 Sep 2023 - 31 Mar 2026
Expired
GRANT
Engineering Immunomodulatory Nanoscale Coatings for Protecting Islet Transplants
National Institute of Health Niddk13 Sep 2020 - 30 Jun 2026
Expired

GRANTS